ORIGINAL STUDIES |
Rerikh K.V., Shchepankevich L.A., Zatynko A.V., Taneeva E.V.
Arterial hypertension as a leading cause of intracerebral haemorrhages in young individuals
|
8-13 |
Geraskina L.A., Maksimova M.Yu., Fonyakin A.V., Garabova N.I., Burzhunova M.G.
Ischemic stroke in case of atrial fibrillation: Influence of previous therapy at the early functional recovery of the patient
|
14-21 |
Ostroumova O.D., Dzamikhov K.K., Kochetkov A.I., Ostroumova Т.М., Shastina V.R., Lyakhova M.A.
Dependence of cognitive profile of multimorbid elderly patients with hypertension from Charlson comorbidity index
|
22-30 |
Galieva A.M., Mukhametova D.D., Belousova E.N., Khazieva G.R., Valitova A.D., Levanova P.I., Odintsova A.Kh., Abdulganieva D.I.
Diagnostical value of methods for cognitive impairments assessing in patients with liver cirrhosis
|
31-38 |
Luzina E.V., Lazebnik L.B., Lareva N.V., Zhilina A.A., Moskvitina A.A.
Peculiarities of clinical manifestations of Helicobacter pylori infection in healthcare professionals
|
39-48 |
Znakharenko E.A., Gerasimenko O.N., Maksimov V.N., Gorbunova A.M.
Association of fibrosis with nutritional status in case of non-alcoholic fatty liver disease
|
49-58 |
Antropova O.N., Nazarova V.V., Voloshina U.E.
Orthostatic hypotension in patients with arterial hypertension and carbohydrate metabolism disorders
|
59-66 |
Gorbunova A.M., Gerasimenko O.N., Shpagin I.S., Belyaeva T.M., Tolmacheva A.A., Maksimov V.N.
Additional diagnostic markers of comorbid version of vibration disease combined with arterial hypertension
|
68-78 |
Beroeva M.R., Mkrtumyan A.M.
Hormonal testosterone replacement therapy in young male patients with hypogonadism and erectile dysfunction after the past COVID-19
|
79-83 |
REVIEWS |
Tanashyan M.M., Antonova K.V., Spryshkov N.E., Panina A.A.
Metabolic markers of cerebrovascular pathology
|
84-92 |
Maksimova M.Yu., Ayrapetova A.S.
Risk factors of brain stroke, specific for female individuals
|
93-100 |
Antonova K.V., Lagoda O.V., Shishkina T.S., Tanashyan M.M.
Metabolic comorbidity in case of cerebrovascular pathology
|
101-110 |
Grigor’eva I.N.
Benefits and problems of physical activity during the COVID-19 pandemic
|
112-121 |
GUIDELINES FOR PRACTITIONERS |
Ostapchuk E.S., Chikviladze S.S.
Wernicke encephalopathy of non-alcoholic genesis
|
122-128 |
Bursikov A.V., Valiullina E.Sh., Kulikov I.V.
Complicated or uncomplicated hypertension crisis: Puzzling aspects of clinical practice
|
130-134 |
LECTURES & REPORTS |
Babak S.L., Gorbunova M.V., Gubernatorova E.E., Malyavin A.G.
Association between diabetes mellitus and lower respiratory tract and pulmonary diseases: Scientific discussion
|
135-143 |
Guideline for practitioners |
Martynov A.I. , Barbarash O.L., Kobalava Zh.D., Malyavin A.G., Boshchenko A.A., Vengerovskii A.I., Zateyshchikov D.A., Chesnikova A.I., Yakushin S.S., Kashtalap V.V., Khazanov V.A., Bykov V.V., Larchenko V.V.
Resolution of the Experts’ Council “Perspective possibilities of using GRS drug in therapeutic practice”
|
144-149 |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
Prikhodko V.A., Okovityi S.V.
Gliflozins as remedies for correction of non-alcoholic fatty liver disease neurological complications. Part 2
|
150-160 |
Shchemeleva E.V., Skorodumova E.A.
Febuxostat: Efficacy and safety of the drug, prospects for application (literature review)
|
162-171 |
Activities of RNMOT |
Digest of interregional scientific and practical events under the aegis or with the participation of RSMSIM (June 2024)
|
172-174 |